Trial attorneys prepare for issues they expect will arise.

On May 14, 2018, in Anacor v. Iancu, the Federal Circuit issued its opinion affirming the Board's invalidation of Anacor's tavaborole patent. The patent-in-suit, U.S. Patent No. 7,582,621 ...

The taxpayer at issue ("Taxpayer") was a corporate subsidiary of MCI, Inc. ("MCI"). For federal income tax purposes, Taxpayer filed as part of the MCI consolidated group.

While most remember the Cuozzo appeal as challenging the Patent Trial & Appeal Board's (PTAB) claim construction practices ...

The Martin Act is one of the most powerful tools in the attorney general's regulatory arsenal because, unlike similar causes of action, it does not require scienter, or intent to defraud.